<--- Back to Details
First PageDocument Content
Business / Economy / Pharmaceutical industry / S&P/TSX 60 Index / S&P/TSX Composite Index / Valeant Pharmaceuticals / Allergan /  Plc / Teva Pharmaceutical Industries / Actavis / Mylan / KP / Perrigo
Business
Economy
Pharmaceutical industry
S&P/TSX 60 Index
S&P/TSX Composite Index
Valeant Pharmaceuticals
Allergan
Plc
Teva Pharmaceutical Industries
Actavis
Mylan
KP
Perrigo

Microsoft PowerPoint - Kurmann Partners - An Overview on M&A in the Pharmaceutical industry - CPhI pre-Connect October.

Add to Reading List

Source URL: www.kurmannpartners.com

Download Document from Source Website

File Size: 1,33 MB

Share Document on Facebook

Similar Documents

Mylan Agrees to Pay $465 Million in Restitution to Resolve False Claims Allegations The National Association of Medicaid Fraud Control units announced on August 17, 2017 that an agreement has been reached to settle alleg

Mylan Agrees to Pay $465 Million in Restitution to Resolve False Claims Allegations The National Association of Medicaid Fraud Control units announced on August 17, 2017 that an agreement has been reached to settle alleg

DocID: 1uUDJ - View Document

Filed on behalf of: Mylan Pharmaceuticals Inc. By: Steven W. Parmelee Michael T. Rosato Jad A. Mills WILSON SONSINI GOODRICH & ROSATI

Filed on behalf of: Mylan Pharmaceuticals Inc. By: Steven W. Parmelee Michael T. Rosato Jad A. Mills WILSON SONSINI GOODRICH & ROSATI

DocID: 1trJa - View Document

IN THE UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD MYLAN PHARMACEUTICALS INC., Petitioner v. SHIRE LABORATORIES, INC.,

IN THE UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD MYLAN PHARMACEUTICALS INC., Petitioner v. SHIRE LABORATORIES, INC.,

DocID: 1tqnl - View Document

Paper No. ____ Filed: November 22, 2016 Filed on behalf of: Mylan Pharmaceuticals Inc. By: Steven W. Parmelee () Michael T. Rosato () Jad A. Mills ()

Paper No. ____ Filed: November 22, 2016 Filed on behalf of: Mylan Pharmaceuticals Inc. By: Steven W. Parmelee () Michael T. Rosato () Jad A. Mills ()

DocID: 1tpON - View Document

Paper No. ____ Filed: May 25, 2016 Filed on behalf of: Mylan Pharmaceuticals Inc. By: Steven W. Parmelee Michael T. Rosato Jad A. Mills

Paper No. ____ Filed: May 25, 2016 Filed on behalf of: Mylan Pharmaceuticals Inc. By: Steven W. Parmelee Michael T. Rosato Jad A. Mills

DocID: 1tkI9 - View Document